# Sandy Mahatme

> Sandy Mahatme is a startup investor at Resilience (Cambridge). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Resilience](https://shizune.co/investors/profile/resilience-e701)
- Location: Cambridge, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sandy-mahatme-77760130/
- X (Twitter): https://twitter.com/SandeshMahatme
- Website: http://sandeshmahatme.com

Sandy Mahatme is a startup investor at Resilience in Cambridge. Sandesh "Sandy" Mahatme is a multi-faceted executive leader who currently serves as the Chief Business Officer, Chief Financial Officer, and Executive Vice President of Sarepta Therapeutics, a leading biotechnology company dedicated to helping patients overcome rare diseases. Through his work at Sarepta, Sandesh has expanded thecompany's financial backing exponentially, closing over $2.5 billion in business development and investment deals. Prior to stepping into these roles. Sandy gained vital experience as Corporate Treasurer, Head of Tax, Senior Vice President of Finance, and Corporate Strategic Development and Initiatives at several other companies. Previously, he also served as Senior Counsel for Pfizer. To glean further insight into Sandesh Mahatme's career, as well as his passion for his current work, be sure to visit his website.

## About Resilience

VC Fund · La Jolla, United States

Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can beproduced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions.

5 contacts available at Resilience.

| Name | Title | Profile |
| --- | --- | --- |
| Bill Reid | CISO and VP, Security and Privacy | https://shizune.co/investors/profile/bill-reid-2 |
| Eytan Abraham | VP, Head of Cell Therapy Franchise | https://shizune.co/investors/profile/eytan-abraham |
| Rahul Singhvi | Co-Founder & CEO | https://shizune.co/investors/profile/rahul-singhvi |
| Ross Leimberg | Senior Director of Business Development | https://shizune.co/investors/profile/ross-leimberg |
| Sandy Mahatme | President, COO and CFO | https://shizune.co/investors/profile/sandesh-mahatme |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co